|
1
|
Nakahama K: Cellular communications in
bone homeostasis and repair. Cell Mol Life Sci. 67:4001–4009. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takeda S, Elefteriou F, Levasseur R, Liu
X, Zhao L, Parker KL, Armstrong D, Ducy P and Karsenty G: Leptin
regulates bone formation via the sympathetic nervous system. Cell.
111:305–317. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Elefteriou F, Ahn JD, Takeda S, Starbuck
M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, et al:
Leptin regulation of bone resorption by the sympathetic nervous
system and CART. Nature. 434:514–520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Serre CM, Farlay D, Delmas PD and Chenu C:
Evidence for a dense and intimate innervation of the bone tissue,
including glutamate-containing fibers. Bone. 25:623–629. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lerner UH, Persson E and Lundberg P:
Kinins and neuro-osteogenic factors. Principles Bone Biol.
2:1025–1057. 2008. View Article : Google Scholar
|
|
6
|
Chenu C and Marenzana M: Sympathetic
nervous system and bone remodeling. Joint Bone Spine. 72:481–483.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Togari A: Adrenergic regulation of bone
metabolism: Possible involvement of sympathetic innervation of
osteoblastic and osteoclastic cells. Microsc Res Tech. 58:77–84.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Toyofuku T, Zhang H, Kumanogoh A,
Takegahara N, Yabuki M, Harada K, Hori M and Kikutani H: Guidance
of myocardial patterning in cardiac development by Sema6D reverse
signaling. Nat Cell Biol. 6:1204–1211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serini G, Valdembri D, Zanivan S, Morterra
G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L,
Logan M, et al: Class 3 semaphorins control vascular morphogenesis
by inhibiting integrin function. Nature. 424:391–397. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sierra JR, Corso S, Caione L, Cepero V,
Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H,
Comoglio PM, et al: Tumor angiogenesis and progression are enhanced
by Sema4D produced by tumor-associated macrophages. J Exp Med.
205:1673–1685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maione F, Molla F, Meda C, Latini R,
Zentilin L, Giacca M, Seano G, Serini G, Bussolino F and Giraudo E:
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks
tumor growth and normalizes tumor vasculature in transgenic mouse
models. J Clin Invest. 119:3356–3372. 2009.PubMed/NCBI
|
|
12
|
Jongbloets BC and Pasterkamp RJ:
Semaphorin signaling during development. Development.
141:3292–3297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo Y, Raible D and Raper JA: Collapsin: A
protein in brain that induces the collapse and paralysis of
neuronal growth cones. Cell. 75:217–227. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tamagnone L and Comoglio PM: To move or
not to move? Semaphorin signaling in cell migration. EBMO Rep.
5:356–361. 2004.
|
|
15
|
Roth L, Koncina E, Satkauskas S, Crémel G,
Aunis D and Bagnard D: The many faces of semaphorins: From
development to pathology. Cell Mol Life Sci. 66:649–666. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Narazaki M and Tosato G: Ligand-induced
internalization selects use of common receptor neuropilin-1 by
VEGF-165 and Semaphorin 3A. Blood. 107:3892–3901. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takegahara N, Takamatsu H, Toyofuku T,
Tsujimura T, Okuno T, Yukawa K, Mizui M, Yamamoto M, Prasad DV,
Suzuki K, et al: Plexin-A1 and its interaction with DAP12 in immune
responses and bone homeostasis. Nat Cell Biol. 8:615–622. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayashi M, Nakashima T, Tanigushi M,
Kodama T, Kumanogoh A and Takayanagi H: Osteoprotection by
Semaphorin 3A. Nature. 485:69–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Negishi-Koga T, Shinohara M, Komatsu N,
Bito H, Kodama T, Friedel RH and Takayanagi H: Suppression of bone
formation by osteoblastic expression of semaphorin 4D. Nature Med.
17:1473–1480. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukuda T, Takeda S, Xu R, Ochi H, Sunamura
S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, et al: Sema3A
regulates bone-mass accrual through sensory innervations. Nature.
497:490–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrette B, Hébert MA, Filali M, Lafortune
K, Vallières N, Gowing G, Julien JP and Lacroix S: Requirement of
myeloid cells for axon regeneration. J Neurosci. 28:9363–9376.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arthur-Farraj PJ, Latouche M, Wilton DK,
Quintes S, Chabrol E, Banerjee A, Woodhoo A, Jenkins B, Rahman M,
Turmaine M, et al: c-Jun reprograms Schwann cells of injured nerves
to generate a repair cell essential for regeneration. Neuron.
75:633–647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jessen KR and Mirsky R: The repair Schwann
cell and its function in regenerating nerves. J Physiol.
594:3521–3531. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huttle RE and Huber AB: Cranial nerve
fasciculation and Schwann cell migration are impaired after loss of
Npn-1. Dev Biol. 359:230–241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tao Y: Isolation and culture of schwann
cells. Methods Mol Biol. 1018:93–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang K, Song W, Wang L, Jia S, Wei H, Ren
S, Xu X and Song Y: Immobilization of chitosan film containing
Semaphorin 3A onto a microarc oxidized titanium implant surface via
silane reaction to improve MG63 osteogenic differentiation. Int J
Nanomedicine. 9:4649–4657. 2014.PubMed/NCBI
|
|
27
|
Saad S, Dharmapatni AASSK, Crotti TN,
Cantley MD, Algate K, Findlay DM, Atkins GJ and Haynes DR:
Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle
induced bone loss. Acta Biomater. 30:311–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai XX, Luo E and Yuan Q: Interaction
between Schwann cells and osteoblasts in vitro. Int J Oral Sci.
2:74–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Z and Tessier-Lavigne M: Neuropilin is
a receptor for the axonal chemorepellent Semaphorin III. Cell.
90:739–751. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huettl RE, Soellner H, Bianchi E, Novitch
BG and Huber AB: Npn-1 contributes to axon-axon interactions that
differentially control sensory and motor innervation of the limb.
PLoS Biol. 9:e10010202011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bouvrée K, Brunet I, Del Toro R, Gordon E,
Prahst C, Cristofaro B, Mathivet T, Xu Y, Soueid J, Fortuna V, et
al: Semaphorin3A, neuropilin-1 and plexinA1 are required for
lymphatic valve formation. Circ Res. 111:437–445. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kawasaki T, Kitsukawa T, Bekku Y, Matsuda
Y, Sanbo M, Yagi T and Fujisawa H: A requirement for neuropilin-1
in embryonic vessel formation. Development. 126:4895–4902.
1999.PubMed/NCBI
|
|
33
|
Cao Y, Hoeppner LH, Bach SEG, Guo Y, Wang
E, Wu J, Cowley MJ, Chang DK, Waddell N, et al: Neuropilin-2
promotes extravasation and metastasis by interacting with
endothelial α5 intergrin. Cancer Res. 73:4579–4590. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nasarre C, Koncina E, Labourdette G,
Cremel G, Roussel G, Aunis D and Bagnard D: Neuropilin-2 acts as a
modulator of Sema3A-dependent glioma cell migration. Cell Adh Migr.
3:383–389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cariboni A, Davidson K, Rakic S, Maggi R,
Parnavelas JG and Ruhrberg C: Defective gonadotropin-releasing
hormone neuron migration in mice lacking SEMA3A signalling through
NRP1 and NRP2: Implications for the aetiology of hypogonadotropic
hypogonadism. Hum Mol Genet. 20:336–344. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan Q, Cho E, Yokota H and Na S: Rac1 and
Cdc42 GTPases regulate shear stress-driven β-catenin signaling in
osteoblasts. Biochem Biophys Res Commun. 433:502–207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Declercq H, Van den Vreken N, De Maeyer E,
Verbeeck R, Schacht E, De Ridder L and Cornelissen M: Isolation,
proliferation and differentiation of osteoblastic cells to study
cell/biomaterial interactions: Comparison of different isolation
techniques and source. Biomaterials. 25:757–768. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Al-Romaih K, Bayani J, Vorobyova J,
Karaskova J, Park PC, Zielenska M and Squire JA: Chromosomal
instability in osteosarcoma and its association with centrosome
abnormalities. Cancer Genet Cytogenet. 144:91–99. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pautke C, Schieker M, Tischer T, Kolk A,
Neth P, Mutschler W and Milz S: Characterization of osteosarcoma
cell lines MG-63, Saos-2 and U-2 OS in comparison to human
osteoblasts. Anticancer Res. 24:3743–3748. 2004.PubMed/NCBI
|
|
40
|
Voegele TJ, Voegele-Kadletz M, Esposito V,
Macfelda K, Oberndorfer U, Vecsei V and Schabus R: The effect of
different isolation techniques on human osteoblast-like cell
growth. Anticancer Res. 20:3575–3581. 2000.PubMed/NCBI
|
|
41
|
Haixia D, Jingsong Z, Lei J, Hairong D,
Jun W, Hang X and Weixian C: Gene expression of neuropilin-1 and
its receptors, VEGF/Semaphorin 3A, in normal and cancer cells. Cell
Biochem Biophys. 59:39–47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rehman M and Tamagnone L: Semaphorins in
cancer: Biological mechanisms and therapeutic approaches. Semin
Cell Dev Biol. 24:179–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vacca A, Scavelli C, Serini G, Di Pietro
G, Cirulli T, Merchionne F, Ribatti D, Bussolino F, Guidolin D,
Piaggio G, et al: Loss of inhibitory Semaphorin 3A (SEMA3A)
autocrine loops in bone marrow endothelial cells of patient with
multiple myeloma. Blood. 108:1661–1667. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Catalano A, Caprari P, Rodilossi S, Betta
P, Castellucci M, Casazza A, Tamagnone L and Procopio A: Cross-talk
between vascular endothelial growth factor and semaphorin-3A
pathway in the regulation of normal and malignant mesothelial cell
proliferation. FASEB J. 18:358–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Herman JG and Meadows GG: Increased class
3 semaphorin expression modulates the invasive and adhesive
properties of prostate cancer cells. Int J Oncol. 30:1231–1238.
2007.PubMed/NCBI
|
|
46
|
Cheng HJ, Bagri A, Yaron A, Stein E,
Pleasure SJ and Tessier-Lavigne M: Plexin-A3 mediates semaphorin
signaling and regulates the development of hippocampal axonal
projections. Neuron. 32:249–263. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ara J, Bannerman P, Hahn A, Ramirez S and
Pleasure D: Modulation of sciatic nerve expression of class 3
semaphorins by nerve injury. Neurochem Res. 29:1153–1159. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Scarlato M, Ara J, Bannerman P, Scherer S
and Pleasure D: Induction of neuropilins-1 and −2 and their
ligands, Sema3A, Sema3F and VEGF, during Wallerian degeneration in
the peripheral nervous system. Exp Neurol. 183:489–498. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Alkhamarah BA, Hoshino N, Kawano Y, Harada
F, Hanada K and Maeda T: The periodontal Ruffini endings in brain
derived neurotrophic factor (BDNF) deficient mice. Arch Histol
Cytol. 66:73–81. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mogi M, Kondo A, Kinpara K and Togari A:
Anti-apoptotic action of nerve growth factor in mouse osteoblastic
cell line. Life Sci. 67:1197–1206. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mizuno N, Shiba H, Xu WP, Inui T, Fujita
T, Kajiya M, Takeda K, Hasegawa N, Kawaguchi H and Kurihara H:
Effect of neurotrophins on differentiation, calcification and
proliferation in cultures of human pulp cells. Cell Biol Int.
31:1462–1469. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Verlinden L, Kriebitzsch C, Beullens I,
Yan BK, Carmeliet G and Verstuyf A: Nrp2 deficiency leads to
trabecular bone loss and is accompanied by enhanced osteoclast and
reduced osteoblast numbers. Bone. 55:465–475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yuan L, Moyon D, Pardanaud L, Bréant C,
Karkkainen MJ, Alitalo K and Eichmann A: Abnormal lymphatic vessel
development in neuropilin 2 mutant mice. Development.
129:4797–4806. 2002.PubMed/NCBI
|
|
54
|
Bannerman P, Ara J, Hahn A, Hong L,
McCauley E, Friesen K and Pleasure D: Peripheral nerve regeneration
is delayed in neuropilin 2-deficient mice. J Neurosci Res.
86:3163–3169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ara J, Bannerman P, Shaheen F and Pleasure
DE: Schwann cell-autonomous role of neuropilin-2. J Neurosci Res.
79:468–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Klineberg I, Calford MB, Dreher B, Henry
P, Macefield V, Miles T, Rowe M, Sessle B and Trulsson M: A
consensus statement on osseoperception. Clin Exp Pharmacol Physiol.
32:145–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
